中文摘要：本发明公开了一种由IL-7融合蛋白组成的药物，IL-7融合蛋白与免疫球蛋白Fc融合，可以预防或治疗流感病毒A导致的疾病。融合蛋白由免疫球蛋白Fc区域和IL-7组成。
 
外文摘要：The present invention relates to a pharmaceutical composition comprising an interleukin-7 fusion protein to which an immunoglobulin Fc region has been fused for preventing or treating diseases caused by influenza virus A. The fusion protein comprising the immunoglobulin Fc region and IL-7 according to the present invention protects the body from infection due to influenza virus A and thus can treat diseases which can be caused by the virus.
NOVELTY - Pharmaceutical composition comprises interleukin-7 (IL-7) fusion protein fused with immunoglobulin (Ig)-fragment crystallizable region (Fc region).
USE - The pharmaceutical composition is useful for preventing or treating disease caused by influenza virus (claimed), and influenza virus infection.
申请号：WO2016KR13966
公开/公告号：WO2017095140A1
申请日：2016-11-30
公开/公告日：2017-06-08
申请/专利权人：GENEXINE INC (GENE-N)
发明/设计人：KANG, M C;CHOI, Y W;CHOI, D;SUNG, Y C
分类号：A61K38/17; A61K38/20; A61K9/00
主分类号：A61K38/17; A61K38/20; A61K9/00
点击下载：一种由免疫球蛋白Fc融合的IL-7融合蛋白组成的可预防或治疗流感病毒的药物